There is no change to our Group outlooks for 2021-2026. GSK continues to expect sales to grow more than 7% on a CAGR basis and Core operating profit to increase more than 11%, on the same basis. Core operating profit margin in 2026 continues to be expected to be more than 31%.

Feb 5, 2025 · “GSK delivered another year of excellent performance in 2024, with strong sales and core profit growth driven by accelerating momentum of our specialty medicines portfolio. This, together with outstanding phase III pipeline progress, means we expect another year of profitable growth in 2025, and have further improved our long-term outlook ...

Dec 20, 2024 · According to GlaxoSmithKline (GSK) statistics, the revenues of the GSK Group in 2024 stood at an impressive $45.6 billion, showing an increase of 7% year on year on the back of vaccines and new...

Feb 5, 2025 · GSK now expects to generate more than 40 billion pound sterling ($50 billion) in 2031 sales, the company said Wednesday alongside its fourth-quarter earnings report. For 2024, the pharma...

Feb 5, 2025 · GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and cancer drugs will...

Jan 31, 2024 · GSK raked in sales of £30.3billion in the last year, thanks to the launch of a new vaccine and booming demand for cancer drugs. The FTSE 100 drugmaker's revenues jumped 5 per cent in 2023 as...

Mar 13, 2025 · GSK – formerly known as GlaxoSmithKline – is among the top 10 global drug manufacturers based on prescription drug sales. It is headquartered in London, and thus, besides AstraZeneca, the...

GSK annual revenue for 2024 was $40.095B, a 6.28% increase from 2023. GSK annual revenue for 2023 was $37.725B , a 4.01% increase from 2022. GSK annual revenue for 2022 was $36.271B , a 22.68% decline from 2021.

Mar 13, 2025 · The statistic shows the global revenue of GSK (GlaxoSmithKline), sorted by region, from 2013 to 2024. In 2024, GSK generated some 6.7 billion British pounds of revenue in Europe.

Jan 31, 2024 · GSK expects its adjusted profit per share to increase between 6% and 9% in 2024, on sales growth of 5%-7%, above analysts' expectations for growth, according to a company-supplied poll.